ADHD/narcolepsy

Adzenys ER Oral Suspension Launched for ADHD

By February 26, 2018

The once-daily medication uses the same modified-release drug delivery technology seen in Adzenys XR-ODT (amphetamine) Extended-Release Orally Disintegrating Tablets.

Are Psychiatric Drugs Being Overprescribed in Children and Adolescents?

By January 30, 2018

"Our results show that, at a population level, prescriptions of stimulants and antidepressant medications for children and adolescents do not appear to be prescribed at rates higher than the known rates for psychiatric conditions they are designed to treat," said the study's lead author, Dr. Ryan Sultan.

AHRQ: Update on ADHD Diagnosis and Treatment

By January 26, 2018

Evidence was contributed from 103 articles describing 90 unique studies.

Shortage of Two ADHD Medications Due to Manufacturing Delays

By January 22, 2018

Quillivant XR and Quillichew ER are currently in short supply.

ADHD Medication Use Increasing Among Reproductive-Aged Women

By January 18, 2018

ADHD medication prescriptions are increasingly common among privately insured, reproductive-aged women.

Maternal Use of ADHD Meds Linked to Neonatal Morbidity

November 13, 2017

Increased risk of neonatal morbidity, especially central nervous system-related disorders

Review Questions Benefits of Common ADHD Med

By November 25, 2015

Findings from a new Cochrane Review caution clinicians to weigh the benefits and risks more carefully when prescribing methylphenidate.

ADHD Meds Up Cardiac Event Risk in Long-QT Syndrome

October 27, 2015

Male patients in particular have an increased risk of cardiac events

Impax Approved for Generic Intuniv

By October 23, 2015

Impax announced that the Food and Drug Administration (FDA) has approved Guanfacine Extended-Release Tablets, the generic version of Shire's Intuniv.

Dyanavel XR Oral Suspension Approved for ADHD

By October 20, 2015

Tris Pharma announced that the FDA has approved Dyanavel XR (amphetamine) extended-release oral suspension for the treatment of attention deficit hyperactivity disorder (ADHD) in children aged ≥6 years.

Trends in Controlled Substance Rxs Highlight Need to Curb Overprescribing

By October 16, 2015

In the first multi-state report from the Centers for Disease Control and Prevention (CDC)'s Prescription Behavior Surveillance System (PBSS), state prescribing practices for prescription opioid pain relievers, benzodiazepines (sedatives/tranquilizers), and stimulants vary significantly despite a similar prevalence of the conditions these medications are intended to treat.

One-Third of Children See PCPs for Mental Health Conditions

October 13, 2015

More than 40 percent of children with ADHD see primary care provider only

New Data Suggest ADHD Rx May Not Pose Threat for Kids With Heart Disease

By October 05, 2015

Researchers from Cincinnati Children's Hospital Medical Center have found no increased mortality or changes in cardiac vital signs among children with congenital heart disease taking attention-deficit/hyperactivity disorder (ADHD) stimulant medications. The study results will be presented at the annual meeting of the Society for Developmental and Behavioral Pediatrics in Las Vegas.

Study: Consider ASD in Children With ADHD Symptoms

September 14, 2015

An initial attention-deficit/hyperactivity disorder (ADHD) diagnosis may be associated with delayed autism spectrum disorder (ASD) diagnosis.

One-Third of U.S. Children With ADHD Diagnosed Before Age 6

September 04, 2015

Almost a third of U.S. children with attention-deficit/hyperactivity disorder (ADHD) were diagnosed before the age of 6, even though there aren't many valid tests to support diagnosis in children that young.

Preterm Birth, Poor Fetal Growth Tied to ADHD Risk

August 25, 2015

Risks of attention-deficit/ hyperactivity disorder (ADHD) are greatest for children with the most severe degree of poor growth in the womb, according to research published in Pediatrics.

Male Teens See Improved Attention, Motor Speed With Citicoline Supplement

By August 11, 2015

After 28 days of citicoline supplementation, adolescent males showed statistically significant increased motor speed, improved attention, and decreased impulsivity in research published in the Journal of Attention Disorders.

Amphetamine XR-ODT NDA Resubmitted for ADHD Treatment

By July 30, 2015

The New Drug Application (NDA) for NT-0202 (amphetamine XR-ODT, Neos) has been resubmitted to the Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD).

Is More Propofol Needed for MRI Sedation in ADHD?

July 27, 2015

Children with attention-deficit/hyperactivity disorder (ADHD) undergoing sedation for magnetic resonance imaging (MRI) do not have a higher dose requirement for propofol.

Antipsychotic Use Up in Adolescents Despite No Mental Health Dx

By July 01, 2015

New research in JAMA Psychiatry reports that use of antipsychotics increased among adolescents and young adults over a four-year period, even though more than half did not have an outpatient or inpatient claim that included a mental disorder diagnosis.

Evekeo Improves ADHD Symptoms, Class Performance Scores in Study

By June 30, 2015

Evekeo (amphetamine sulfate; Arbor) tablets administered once or twice daily to children aged 6 to 12 years was effective in treating attention deficit hyperactivity disorder (ADHD) symptoms and improving performance in a laboratory classroom setting, reports a new study.

FDA: Derm Dilemma with Daytrana

By June 24, 2015

The Food and Drug Administration (FDA) has issued a warning that the use of Daytrana patch (methylphenidate transdermal system; Noven) may result in permanent loss of skin color.

Evekeo Available for the Treatment of ADHD

By June 22, 2015

Evekeo (amphetamine sulfate; Arbor) tablets are available for the treatment of attention deficit hyperactivity disorder (ADHD) as part of a total treatment program in patients aged 3 years and older.

Teva's Generic Focalin XR Available in New Strength

By June 22, 2015

Teva announced the launch of Dexmethylphenidate HCl Extended-Release Capsules in a new 20mg strength, the generic of Novartis' Focalin XR.

Fidgeting May Actually Help Children with ADHD Focus

June 12, 2015

Small study found those who fidgeted intensely performed better on a test

ADHD Drug Helps Women With Menopause-Related Cognitive Issues in Study

By June 11, 2015

A drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and binge eating disorder also helped women with executive functions related to menopause in research appearing in the journal Psychopharmacology.

Birth Month May Indeed Help Predict Disease Risk

By June 08, 2015

A new algorithm developed by scientists at Columbia University Medical Center (CUMC) supports previously reported associations between a person's birth month and overall disease risk, including 16 new links that include nine types of heart disease.

Psychotropic Medication Use in Children With Down Sx Appears Age-Related

By June 08, 2015

Trends in use of psychotropic medication in children and adolescents with Down syndrome (DS) appear to be age-related, as a new study in the Journal of Developmental & Behavioral Pediatrics suggests that teens and young adults are significantly more likely to be on psychotropic medications compared to younger children.

Stimulant Misuse May Begin Earlier Than Expected

June 08, 2015

Misuse of prescription stimulant medications such as Ritalin and Adderall may begin at an earlier age than previously believed.

Generic Versions of Intuniv Launched

By June 04, 2015

Sandoz, Teva, and TWi Pharmaceuticals announced the launch of Guanfacine HCl Extended-Release Tablets, the generic version of Shire's Intuniv.